Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Spasms, Infantile | 10 | 2024 | 298 | 1.590 |
Why?
|
Models, Statistical | 6 | 2021 | 5081 | 1.220 |
Why?
|
Epilepsy | 14 | 2023 | 3304 | 0.990 |
Why?
|
China | 13 | 2024 | 2374 | 0.810 |
Why?
|
Hepatoblastoma | 1 | 2022 | 90 | 0.790 |
Why?
|
Device Approval | 1 | 2022 | 163 | 0.700 |
Why?
|
Likelihood Functions | 4 | 2017 | 991 | 0.640 |
Why?
|
Linear Models | 7 | 2023 | 5869 | 0.540 |
Why?
|
Research Subjects | 1 | 2018 | 249 | 0.530 |
Why?
|
Spastic Paraplegia, Hereditary | 3 | 2023 | 168 | 0.530 |
Why?
|
Statistics, Nonparametric | 4 | 2018 | 2854 | 0.520 |
Why?
|
Health Expenditures | 2 | 2018 | 2362 | 0.480 |
Why?
|
Spasm | 9 | 2024 | 130 | 0.460 |
Why?
|
Models, Economic | 1 | 2018 | 714 | 0.450 |
Why?
|
Cluster Analysis | 3 | 2023 | 2706 | 0.450 |
Why?
|
Neuroblastoma | 1 | 2022 | 1246 | 0.440 |
Why?
|
Central Nervous System Neoplasms | 1 | 2022 | 915 | 0.440 |
Why?
|
Hearing Loss | 1 | 2021 | 782 | 0.440 |
Why?
|
Models, Theoretical | 2 | 2023 | 3571 | 0.420 |
Why?
|
Depression | 7 | 2024 | 8132 | 0.420 |
Why?
|
Clinical Trials as Topic | 3 | 2019 | 8003 | 0.420 |
Why?
|
Status Epilepticus | 3 | 2023 | 461 | 0.410 |
Why?
|
Computer Simulation | 8 | 2023 | 6224 | 0.400 |
Why?
|
Seizures | 14 | 2024 | 2965 | 0.400 |
Why?
|
Hypoparathyroidism | 3 | 2021 | 136 | 0.400 |
Why?
|
Cesarean Section | 1 | 2019 | 1399 | 0.360 |
Why?
|
Endometriosis | 4 | 2012 | 870 | 0.350 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2022 | 2293 | 0.340 |
Why?
|
Data Interpretation, Statistical | 3 | 2019 | 2691 | 0.340 |
Why?
|
Longitudinal Studies | 8 | 2023 | 14610 | 0.330 |
Why?
|
Electroencephalography | 14 | 2024 | 6242 | 0.330 |
Why?
|
Intensive Care Units | 1 | 2023 | 3744 | 0.330 |
Why?
|
Professional Competence | 1 | 2012 | 430 | 0.330 |
Why?
|
Algorithms | 6 | 2023 | 14025 | 0.290 |
Why?
|
Humans | 94 | 2024 | 761208 | 0.290 |
Why?
|
Cerebral Palsy | 2 | 2022 | 477 | 0.290 |
Why?
|
SEER Program | 2 | 2022 | 1453 | 0.280 |
Why?
|
Vigabatrin | 3 | 2023 | 88 | 0.280 |
Why?
|
Health Policy | 1 | 2019 | 2679 | 0.280 |
Why?
|
Liver Neoplasms | 1 | 2022 | 4309 | 0.270 |
Why?
|
Child | 33 | 2024 | 80152 | 0.270 |
Why?
|
Research Design | 3 | 2019 | 6180 | 0.260 |
Why?
|
Biostatistics | 3 | 2019 | 164 | 0.250 |
Why?
|
Diagnostic Errors | 1 | 2012 | 1265 | 0.240 |
Why?
|
Anticonvulsants | 7 | 2023 | 1910 | 0.240 |
Why?
|
Tuberous Sclerosis | 2 | 2023 | 1031 | 0.240 |
Why?
|
Medicare | 1 | 2023 | 6773 | 0.240 |
Why?
|
Brain Diseases | 2 | 2023 | 1545 | 0.230 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5842 | 0.230 |
Why?
|
Stroke | 2 | 2023 | 9721 | 0.220 |
Why?
|
Opsoclonus-Myoclonus Syndrome | 1 | 2023 | 9 | 0.220 |
Why?
|
Adaptor Protein Complex 4 | 1 | 2023 | 40 | 0.210 |
Why?
|
Schools | 4 | 2024 | 1483 | 0.200 |
Why?
|
Vasculitis, Central Nervous System | 1 | 2022 | 45 | 0.200 |
Why?
|
Female | 49 | 2024 | 392544 | 0.200 |
Why?
|
Central Nervous System Viral Diseases | 1 | 2022 | 40 | 0.200 |
Why?
|
Myelitis | 1 | 2022 | 49 | 0.200 |
Why?
|
Electronic Health Records | 1 | 2019 | 4822 | 0.200 |
Why?
|
Marriage | 1 | 2024 | 349 | 0.200 |
Why?
|
Enterovirus Infections | 1 | 2022 | 74 | 0.200 |
Why?
|
Hamartoma Syndrome, Multiple | 1 | 2022 | 114 | 0.190 |
Why?
|
Pentylenetetrazole | 1 | 2021 | 71 | 0.190 |
Why?
|
Convulsants | 1 | 2021 | 70 | 0.190 |
Why?
|
Parathyroid Hormone | 3 | 2021 | 1803 | 0.190 |
Why?
|
Adolescent | 21 | 2024 | 88298 | 0.190 |
Why?
|
Health Behavior | 3 | 2023 | 2641 | 0.190 |
Why?
|
Myasthenic Syndromes, Congenital | 1 | 2021 | 17 | 0.180 |
Why?
|
Adrenocorticotropic Hormone | 4 | 2023 | 617 | 0.180 |
Why?
|
Malaria, Cerebral | 1 | 2022 | 136 | 0.180 |
Why?
|
Male | 41 | 2024 | 360693 | 0.180 |
Why?
|
Alcoholic Beverages | 1 | 2022 | 264 | 0.180 |
Why?
|
Cytoplasmic Dyneins | 1 | 2020 | 24 | 0.180 |
Why?
|
Mental Health | 3 | 2023 | 3251 | 0.170 |
Why?
|
Cross-Sectional Studies | 8 | 2024 | 26071 | 0.170 |
Why?
|
Probability | 2 | 2023 | 2478 | 0.170 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2023 | 10218 | 0.170 |
Why?
|
Neuromuscular Diseases | 1 | 2022 | 260 | 0.170 |
Why?
|
Movement Disorders | 1 | 2023 | 459 | 0.170 |
Why?
|
Pathology, Molecular | 1 | 2022 | 329 | 0.170 |
Why?
|
Charcot-Marie-Tooth Disease | 1 | 2020 | 100 | 0.170 |
Why?
|
Unsafe Sex | 2 | 2018 | 238 | 0.160 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2022 | 269 | 0.160 |
Why?
|
Galvanic Skin Response | 1 | 2021 | 358 | 0.160 |
Why?
|
Ancylostomiasis | 1 | 2018 | 5 | 0.160 |
Why?
|
Ancylostoma | 1 | 2018 | 10 | 0.160 |
Why?
|
Chromosome Disorders | 1 | 2021 | 497 | 0.150 |
Why?
|
Myasthenia Gravis | 1 | 2021 | 214 | 0.150 |
Why?
|
Social Isolation | 1 | 2021 | 365 | 0.150 |
Why?
|
Melatonin | 1 | 2023 | 668 | 0.150 |
Why?
|
Therapies, Investigational | 1 | 2019 | 111 | 0.150 |
Why?
|
Hemolysin Proteins | 1 | 2018 | 113 | 0.150 |
Why?
|
Intestinal Diseases, Parasitic | 1 | 2018 | 64 | 0.150 |
Why?
|
Nicotinic Antagonists | 1 | 2018 | 94 | 0.150 |
Why?
|
Sample Size | 2 | 2019 | 843 | 0.150 |
Why?
|
Muscle Weakness | 1 | 2021 | 412 | 0.150 |
Why?
|
Rural Population | 4 | 2023 | 2277 | 0.150 |
Why?
|
Anthelmintics | 1 | 2018 | 83 | 0.150 |
Why?
|
Bullying | 1 | 2020 | 232 | 0.140 |
Why?
|
Epilepsies, Partial | 1 | 2021 | 431 | 0.140 |
Why?
|
Vision Disorders | 2 | 2023 | 1088 | 0.140 |
Why?
|
Muscular Atrophy, Spinal | 1 | 2020 | 260 | 0.140 |
Why?
|
United States | 7 | 2023 | 72339 | 0.130 |
Why?
|
Equipment and Supplies | 1 | 2019 | 273 | 0.130 |
Why?
|
Chromosome Deletion | 1 | 2021 | 1386 | 0.130 |
Why?
|
Alcohol Drinking | 2 | 2022 | 4027 | 0.130 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2022 | 870 | 0.130 |
Why?
|
Stress Disorders, Post-Traumatic | 3 | 2023 | 4575 | 0.130 |
Why?
|
Endotoxins | 1 | 2018 | 520 | 0.130 |
Why?
|
Incidence | 3 | 2024 | 21365 | 0.130 |
Why?
|
Parturition | 1 | 2019 | 447 | 0.130 |
Why?
|
Pandemics | 7 | 2023 | 8663 | 0.120 |
Why?
|
Biometry | 1 | 2018 | 563 | 0.120 |
Why?
|
Behavior, Addictive | 1 | 2020 | 462 | 0.120 |
Why?
|
Toxicity Tests | 1 | 2015 | 115 | 0.120 |
Why?
|
Infant | 11 | 2024 | 36169 | 0.120 |
Why?
|
Cross-Over Studies | 2 | 2019 | 2082 | 0.120 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2024 | 1549 | 0.120 |
Why?
|
Skilled Nursing Facilities | 1 | 2019 | 400 | 0.120 |
Why?
|
Cell Nucleus | 1 | 2023 | 2881 | 0.110 |
Why?
|
Ethylene Glycols | 1 | 2015 | 196 | 0.110 |
Why?
|
Social Support | 2 | 2023 | 2175 | 0.110 |
Why?
|
Retrospective Studies | 17 | 2024 | 80674 | 0.110 |
Why?
|
Vitamin E Deficiency | 1 | 2013 | 30 | 0.110 |
Why?
|
Methyl Ethers | 1 | 2015 | 197 | 0.110 |
Why?
|
Aged | 11 | 2023 | 169288 | 0.110 |
Why?
|
United States Food and Drug Administration | 1 | 2022 | 1662 | 0.110 |
Why?
|
Child, Preschool | 11 | 2023 | 42224 | 0.110 |
Why?
|
Caenorhabditis elegans | 1 | 2022 | 1453 | 0.110 |
Why?
|
Residence Characteristics | 1 | 2023 | 2092 | 0.110 |
Why?
|
alpha-Tocopherol | 1 | 2013 | 126 | 0.110 |
Why?
|
Syndrome | 3 | 2024 | 3271 | 0.110 |
Why?
|
Autistic Disorder | 1 | 2022 | 1222 | 0.100 |
Why?
|
Biomarkers, Pharmacological | 1 | 2013 | 161 | 0.100 |
Why?
|
Phosphorus | 3 | 2021 | 332 | 0.100 |
Why?
|
Body Height | 1 | 2018 | 1566 | 0.100 |
Why?
|
Suicide | 1 | 2023 | 1602 | 0.100 |
Why?
|
Choice Behavior | 1 | 2018 | 825 | 0.100 |
Why?
|
Educational Status | 3 | 2024 | 2510 | 0.100 |
Why?
|
Child Abuse | 1 | 2020 | 1076 | 0.090 |
Why?
|
Ethylene Glycol | 1 | 2011 | 31 | 0.090 |
Why?
|
Hormone Replacement Therapy | 2 | 2018 | 751 | 0.090 |
Why?
|
Body Mass Index | 2 | 2019 | 12952 | 0.090 |
Why?
|
Bone Remodeling | 1 | 2014 | 583 | 0.090 |
Why?
|
Nursing Homes | 1 | 2018 | 1083 | 0.090 |
Why?
|
Calcium | 2 | 2021 | 5719 | 0.090 |
Why?
|
Infant, Newborn | 2 | 2022 | 26199 | 0.090 |
Why?
|
Accidental Falls | 1 | 2018 | 1068 | 0.090 |
Why?
|
Labor, Obstetric | 1 | 2013 | 323 | 0.090 |
Why?
|
Quality of Life | 2 | 2023 | 13367 | 0.090 |
Why?
|
Microarray Analysis | 2 | 2023 | 748 | 0.090 |
Why?
|
Hip Fractures | 1 | 2018 | 989 | 0.090 |
Why?
|
Monte Carlo Method | 2 | 2015 | 1256 | 0.090 |
Why?
|
Myocardium | 1 | 2023 | 4746 | 0.090 |
Why?
|
Brain Injuries | 1 | 2021 | 2054 | 0.080 |
Why?
|
Organogenesis | 1 | 2011 | 214 | 0.080 |
Why?
|
Genetic Testing | 4 | 2023 | 3537 | 0.080 |
Why?
|
Polychlorinated Biphenyls | 1 | 2011 | 236 | 0.080 |
Why?
|
Hospitals | 1 | 2023 | 3881 | 0.080 |
Why?
|
Anxiety | 2 | 2023 | 4569 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 2 | 2022 | 17897 | 0.080 |
Why?
|
Diagnostic Tests, Routine | 1 | 2015 | 788 | 0.080 |
Why?
|
Rabbits | 1 | 2015 | 4750 | 0.080 |
Why?
|
Logistic Models | 2 | 2021 | 13249 | 0.080 |
Why?
|
Tibia | 1 | 2014 | 1070 | 0.080 |
Why?
|
Patient Readmission | 1 | 2023 | 3265 | 0.080 |
Why?
|
Cholesterol, LDL | 1 | 2018 | 2380 | 0.080 |
Why?
|
Survival Analysis | 1 | 2021 | 10088 | 0.080 |
Why?
|
ROC Curve | 2 | 2015 | 3584 | 0.080 |
Why?
|
Critical Illness | 1 | 2021 | 2724 | 0.080 |
Why?
|
Hippocampus | 1 | 2021 | 3754 | 0.070 |
Why?
|
Quality of Health Care | 1 | 2023 | 4320 | 0.070 |
Why?
|
Chronic Disease | 1 | 2022 | 9319 | 0.070 |
Why?
|
Reproducibility of Results | 3 | 2015 | 20119 | 0.070 |
Why?
|
Cohort Studies | 7 | 2023 | 41496 | 0.070 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12474 | 0.070 |
Why?
|
Treatment Outcome | 9 | 2023 | 64681 | 0.070 |
Why?
|
Vaccines | 1 | 2014 | 835 | 0.070 |
Why?
|
Substance-Related Disorders | 1 | 2022 | 4413 | 0.060 |
Why?
|
Registries | 1 | 2022 | 8247 | 0.060 |
Why?
|
Reference Values | 1 | 2012 | 4921 | 0.060 |
Why?
|
Middle Aged | 10 | 2023 | 220853 | 0.060 |
Why?
|
Sexual Behavior | 1 | 2015 | 2189 | 0.060 |
Why?
|
Social Class | 2 | 2024 | 1993 | 0.060 |
Why?
|
Bacterial Proteins | 1 | 2018 | 3836 | 0.060 |
Why?
|
Pregnancy | 4 | 2023 | 29893 | 0.060 |
Why?
|
Phenotype | 4 | 2023 | 16575 | 0.060 |
Why?
|
Monitoring, Physiologic | 2 | 2022 | 1780 | 0.060 |
Why?
|
Activities of Daily Living | 1 | 2013 | 2420 | 0.060 |
Why?
|
DNA Copy Number Variations | 2 | 2022 | 2024 | 0.060 |
Why?
|
Osteoporosis | 1 | 2013 | 1604 | 0.060 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2018 | 3417 | 0.050 |
Why?
|
Failure to Thrive | 1 | 2023 | 140 | 0.050 |
Why?
|
Intermediate Filaments | 1 | 2023 | 171 | 0.050 |
Why?
|
Porins | 1 | 2022 | 78 | 0.050 |
Why?
|
Muscle Hypotonia | 1 | 2023 | 161 | 0.050 |
Why?
|
Breast Neoplasms | 2 | 2023 | 20982 | 0.050 |
Why?
|
Entropy | 1 | 2022 | 210 | 0.050 |
Why?
|
Zambia | 1 | 2022 | 271 | 0.050 |
Why?
|
Prospective Studies | 5 | 2023 | 54435 | 0.050 |
Why?
|
Muscle Spasticity | 1 | 2022 | 157 | 0.050 |
Why?
|
Young Adult | 5 | 2024 | 59221 | 0.050 |
Why?
|
Adult | 10 | 2024 | 221119 | 0.050 |
Why?
|
Ataxia | 1 | 2023 | 305 | 0.050 |
Why?
|
Risk Factors | 3 | 2024 | 74239 | 0.050 |
Why?
|
Mice, Inbred CBA | 1 | 2021 | 438 | 0.040 |
Why?
|
Mice, 129 Strain | 1 | 2021 | 370 | 0.040 |
Why?
|
Bone Density | 1 | 2013 | 3546 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2013 | 4935 | 0.040 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2021 | 346 | 0.040 |
Why?
|
Prescriptions | 1 | 2022 | 386 | 0.040 |
Why?
|
Personality Inventory | 1 | 2023 | 1018 | 0.040 |
Why?
|
HIV Infections | 2 | 2018 | 17347 | 0.040 |
Why?
|
Glasgow Coma Scale | 1 | 2021 | 580 | 0.040 |
Why?
|
Calcitriol | 1 | 2021 | 295 | 0.040 |
Why?
|
Area Under Curve | 2 | 2015 | 1636 | 0.040 |
Why?
|
School Health Services | 1 | 2023 | 384 | 0.040 |
Why?
|
Personality | 1 | 2023 | 553 | 0.040 |
Why?
|
Virulence Factors | 1 | 2022 | 511 | 0.040 |
Why?
|
Delayed Diagnosis | 1 | 2023 | 465 | 0.040 |
Why?
|
Epilepsy, Generalized | 1 | 2021 | 178 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2023 | 12341 | 0.040 |
Why?
|
Dementia | 1 | 2013 | 2684 | 0.040 |
Why?
|
Corpus Callosum | 1 | 2023 | 750 | 0.040 |
Why?
|
Nephrocalcinosis | 1 | 2018 | 52 | 0.040 |
Why?
|
Parents | 2 | 2023 | 3564 | 0.040 |
Why?
|
Job Satisfaction | 1 | 2022 | 545 | 0.040 |
Why?
|
Polyendocrinopathies, Autoimmune | 1 | 2018 | 56 | 0.040 |
Why?
|
Mutation | 4 | 2023 | 30002 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2012 | 3534 | 0.040 |
Why?
|
Malformations of Cortical Development | 1 | 2020 | 176 | 0.040 |
Why?
|
Homozygote | 1 | 2023 | 1775 | 0.040 |
Why?
|
Mesocricetus | 1 | 2018 | 252 | 0.040 |
Why?
|
Japan | 1 | 2022 | 1378 | 0.040 |
Why?
|
Sex Factors | 2 | 2023 | 10553 | 0.040 |
Why?
|
Horse Diseases | 1 | 2018 | 55 | 0.040 |
Why?
|
Animals | 7 | 2022 | 168079 | 0.040 |
Why?
|
Horses | 1 | 2018 | 296 | 0.040 |
Why?
|
Parent-Child Relations | 1 | 2022 | 762 | 0.040 |
Why?
|
Vitamin D | 3 | 2018 | 3301 | 0.040 |
Why?
|
Receptors, Calcium-Sensing | 1 | 2018 | 318 | 0.040 |
Why?
|
Time Factors | 4 | 2021 | 39957 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 14675 | 0.040 |
Why?
|
Observation | 1 | 2019 | 310 | 0.040 |
Why?
|
Species Specificity | 1 | 2021 | 2406 | 0.030 |
Why?
|
Age of Onset | 1 | 2024 | 3307 | 0.030 |
Why?
|
Stress, Psychological | 2 | 2022 | 4487 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2022 | 1111 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2023 | 846 | 0.030 |
Why?
|
Kidney Function Tests | 1 | 2018 | 680 | 0.030 |
Why?
|
Environmental Exposure | 1 | 2011 | 4479 | 0.030 |
Why?
|
Homes for the Aged | 1 | 2018 | 273 | 0.030 |
Why?
|
Parenting | 1 | 2022 | 701 | 0.030 |
Why?
|
Aging | 3 | 2022 | 8702 | 0.030 |
Why?
|
Video Recording | 1 | 2021 | 965 | 0.030 |
Why?
|
Reward | 1 | 2022 | 968 | 0.030 |
Why?
|
Biomedical Research | 1 | 2011 | 3434 | 0.030 |
Why?
|
Central Nervous System | 1 | 2022 | 1333 | 0.030 |
Why?
|
Self-Injurious Behavior | 1 | 2021 | 566 | 0.030 |
Why?
|
Benzodiazepines | 1 | 2021 | 1134 | 0.030 |
Why?
|
Haversian System | 1 | 2014 | 9 | 0.030 |
Why?
|
Actins | 1 | 2022 | 2046 | 0.030 |
Why?
|
Cognition | 2 | 2023 | 6988 | 0.030 |
Why?
|
Attitude | 1 | 2020 | 771 | 0.030 |
Why?
|
Urban Population | 1 | 2023 | 2036 | 0.030 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2021 | 1990 | 0.030 |
Why?
|
Glycoproteins | 1 | 2022 | 2203 | 0.030 |
Why?
|
Thinness | 1 | 2018 | 481 | 0.030 |
Why?
|
Receptors, Nicotinic | 1 | 2018 | 494 | 0.030 |
Why?
|
Diaphyses | 1 | 2014 | 65 | 0.030 |
Why?
|
Cricetinae | 1 | 2018 | 2412 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2023 | 1878 | 0.030 |
Why?
|
Myocytes, Cardiac | 1 | 2023 | 1666 | 0.030 |
Why?
|
Cost of Illness | 1 | 2024 | 1936 | 0.030 |
Why?
|
Porosity | 1 | 2014 | 348 | 0.030 |
Why?
|
Poisson Distribution | 1 | 2015 | 504 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 22140 | 0.030 |
Why?
|
Heterozygote | 1 | 2020 | 2778 | 0.030 |
Why?
|
Outpatients | 1 | 2021 | 1598 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2022 | 2058 | 0.030 |
Why?
|
Disease Outbreaks | 1 | 2023 | 1747 | 0.030 |
Why?
|
RNA | 1 | 2023 | 2709 | 0.030 |
Why?
|
Creatinine | 1 | 2018 | 1897 | 0.030 |
Why?
|
Family | 1 | 2023 | 3192 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2023 | 39126 | 0.030 |
Why?
|
Alzheimer Disease | 1 | 2013 | 8603 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2023 | 2451 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2023 | 1847 | 0.020 |
Why?
|
Collagen Type I | 1 | 2014 | 616 | 0.020 |
Why?
|
X-Ray Microtomography | 1 | 2013 | 450 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2020 | 2567 | 0.020 |
Why?
|
Health Promotion | 1 | 2023 | 2205 | 0.020 |
Why?
|
Infusion Pumps | 1 | 2011 | 163 | 0.020 |
Why?
|
Heart Rate | 1 | 2022 | 4197 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2023 | 3410 | 0.020 |
Why?
|
Disease Progression | 2 | 2021 | 13511 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2018 | 4107 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2022 | 3634 | 0.020 |
Why?
|
Injections, Subcutaneous | 1 | 2011 | 672 | 0.020 |
Why?
|
Insulin Infusion Systems | 1 | 2011 | 217 | 0.020 |
Why?
|
Health Status | 1 | 2023 | 4077 | 0.020 |
Why?
|
Calcinosis | 1 | 2018 | 1477 | 0.020 |
Why?
|
Recurrence | 1 | 2022 | 8457 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2021 | 22127 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15841 | 0.020 |
Why?
|
DNA | 1 | 2023 | 7189 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2023 | 3200 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2576 | 0.020 |
Why?
|
Internet | 1 | 2020 | 3096 | 0.020 |
Why?
|
Boston | 1 | 2021 | 9327 | 0.020 |
Why?
|
Proteins | 1 | 2023 | 5993 | 0.020 |
Why?
|
Abnormalities, Drug-Induced | 1 | 2011 | 339 | 0.020 |
Why?
|
Comorbidity | 1 | 2023 | 10516 | 0.020 |
Why?
|
Magnesium | 1 | 2011 | 804 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2018 | 6304 | 0.020 |
Why?
|
Macaca mulatta | 1 | 2014 | 2328 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2019 | 58952 | 0.020 |
Why?
|
Epidemiologic Research Design | 1 | 2011 | 368 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2013 | 2569 | 0.020 |
Why?
|
Homeostasis | 1 | 2018 | 3320 | 0.020 |
Why?
|
Pain | 1 | 2022 | 5072 | 0.020 |
Why?
|
Absorptiometry, Photon | 1 | 2013 | 1738 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2021 | 5295 | 0.020 |
Why?
|
Overweight | 1 | 2018 | 2418 | 0.020 |
Why?
|
Femur | 1 | 2013 | 1308 | 0.020 |
Why?
|
Exercise | 1 | 2023 | 5874 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2022 | 3805 | 0.020 |
Why?
|
Obesity | 2 | 2019 | 12939 | 0.020 |
Why?
|
Patient Discharge | 1 | 2019 | 3441 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2013 | 2138 | 0.020 |
Why?
|
Mice | 3 | 2021 | 81326 | 0.010 |
Why?
|
Viral Load | 1 | 2013 | 3328 | 0.010 |
Why?
|
Age Factors | 1 | 2021 | 18384 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2011 | 4851 | 0.010 |
Why?
|
Peptides | 1 | 2014 | 4353 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2013 | 8164 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2013 | 3114 | 0.010 |
Why?
|
Prognosis | 1 | 2022 | 29687 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2013 | 7046 | 0.010 |
Why?
|
Pregnancy Outcome | 1 | 2011 | 2923 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12052 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2013 | 14392 | 0.010 |
Why?
|
Rats | 1 | 2013 | 23704 | 0.010 |
Why?
|
Diet | 1 | 2013 | 8048 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 36415 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2011 | 15637 | 0.010 |
Why?
|